Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 11  •  04:00PM ET
226.35
Dollar change
+33.31
Percentage change
17.26
%
Today, 1:56 PMTenet Healthcare posts strong Q4 results with a 2025 beat and solid 2026 EBITDA guidance despite exchange headwinds, and on its Q4 2025 earnings call said the completed Conifer transaction retires $885M of obligations and will produce a one-time $40M favorable revenue adjustment in 2026.
Index- P/E15.52 EPS (ttm)14.59 Insider Own0.75% Shs Outstand87.87M Perf Week18.72%
Market Cap19.89B Forward P/E13.06 EPS next Y17.33 Insider Trans-17.13% Shs Float87.23M Perf Month13.40%
Enterprise Value34.79B PEG2.05 EPS next Q4.42 Inst Own96.42% Short Float3.12% Perf Quarter16.27%
Income1.35B P/S0.95 EPS this Y-1.37% Inst Trans-3.56% Short Ratio2.93 Perf Half Y32.77%
Sales20.86B P/B4.95 EPS next Y4.73% ROA4.61% Short Interest2.72M Perf YTD13.90%
Book/sh45.68 P/C6.69 EPS next 5Y6.37% ROE34.51% 52W High222.82 1.59% Perf Year63.04%
Cash/sh33.85 P/FCF13.24 EPS past 3/5Y57.18% - ROIC7.91% 52W Low109.82 106.10% Perf 3Y285.93%
Dividend Est.- EV/EBITDA8.34 Sales past 3/5Y1.98% 2.26% Gross Margin16.04% Volatility7.51% 4.17% Perf 5Y347.86%
Dividend TTM- EV/Sales1.67 EPS Y/Y TTM-53.50% Oper. Margin16.04% ATR (14)8.92 Perf 10Y867.72%
Dividend Ex-Date- Quick Ratio1.64 Sales Y/Y TTM-0.56% Profit Margin6.49% RSI (14)72.74 Recom1.38
Dividend Gr. 3/5Y- - Current Ratio1.71 EPS Q/Q-21.13% SMA2016.55% Beta1.44 Target Price243.00
Payout0.00% Debt/Eq3.29 Sales Q/Q3.26% SMA5013.76% Rel Volume3.65 Prev Close193.04
Employees98000 LT Debt/Eq3.26 EarningsFeb 11 BMO SMA20022.68% Avg Volume929.41K Price226.35
IPOApr 28, 1971 Option/ShortYes / Yes EPS/Sales Surpr.15.62% 1.01% Trades Volume3,392,842 Change17.26%
Date Action Analyst Rating Change Price Target Change
Oct-14-25Resumed Goldman Buy $224
Jul-28-25Downgrade Wolfe Research Outperform → Peer Perform
May-29-25Upgrade Wells Fargo Equal Weight → Overweight $195
Apr-15-25Downgrade Robert W. Baird Outperform → Neutral $137
Mar-26-25Initiated Morgan Stanley Overweight $165
Feb-26-25Initiated TD Cowen Buy $175
Dec-17-24Resumed JP Morgan Overweight $175
Dec-16-24Downgrade Goldman Buy → Neutral $196 → $140
Nov-25-24Downgrade Wells Fargo Overweight → Equal Weight $205 → $150
Nov-22-24Downgrade Raymond James Strong Buy → Outperform $195
Today 04:16PM
04:05PM
12:34PM
12:32PM
09:30AM
07:55AM Loading…
07:55AM
07:08AM
07:02AM
07:00AM
06:45AM
Feb-10-26 12:23PM
Feb-09-26 10:07PM
Feb-06-26 09:21AM
Feb-05-26 09:45AM
Feb-04-26 12:10PM
10:00AM Loading…
10:00AM
09:40AM
08:55AM
Feb-03-26 07:00PM
06:00PM
03:02AM
Feb-02-26 06:45AM
04:03AM
Jan-29-26 09:00AM
Jan-22-26 09:30AM
Jan-21-26 08:14PM
Jan-20-26 06:15PM
Jan-15-26 03:10PM
09:00AM
Jan-14-26 06:00PM
05:30AM Loading…
Jan-13-26 05:30AM
Jan-09-26 05:12AM
Jan-08-26 09:34AM
Jan-07-26 06:00PM
09:45AM
09:00AM
Jan-06-26 09:40AM
Jan-05-26 10:37PM
Dec-26-25 06:00PM
Dec-25-25 02:05PM
Dec-23-25 09:11AM
Dec-22-25 09:45AM
Dec-19-25 06:00PM
06:55AM
Dec-18-25 12:17PM
09:00AM
Dec-17-25 01:30PM
12:19PM
09:30AM
Dec-10-25 09:50AM
Dec-05-25 09:45AM
Dec-04-25 09:40AM
09:00AM
Dec-03-25 09:12AM
Dec-01-25 11:23AM
Nov-27-25 11:30AM
Nov-26-25 08:30AM
Nov-24-25 07:19PM
12:40PM
Nov-20-25 09:00AM
Nov-19-25 09:45AM
Nov-18-25 09:40AM
Nov-17-25 07:57PM
06:07AM
Nov-14-25 05:08PM
Nov-13-25 05:16AM
Nov-12-25 02:05PM
02:31AM
Nov-11-25 01:26PM
Nov-10-25 04:26PM
12:55PM
10:19AM
06:14AM
06:14AM
Nov-06-25 09:00AM
Nov-04-25 12:38AM
Nov-03-25 11:01PM
05:25PM
08:51AM
Nov-01-25 02:00PM
Oct-31-25 09:45AM
Oct-30-25 03:18PM
09:50AM
Oct-29-25 11:18AM
10:05AM
09:40AM
04:46AM
Oct-28-25 02:35PM
01:05PM
10:30AM
07:55AM
07:08AM
06:53AM
06:45AM
Oct-27-25 05:30PM
Oct-26-25 11:10PM
Oct-23-25 12:42PM
09:00AM
Oct-22-25 06:00PM
Oct-15-25 06:00PM
Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Ambulatory Care segments. The Hospital Operations segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
West NadjaDirectorDec 15 '25Sale197.472,178430,09028,480Dec 17 08:00 PM
West NadjaDirectorDec 15 '25Proposed Sale197.472,178430,097Dec 15 03:41 PM
Ramsey R. ScottPrincipal Accounting OfficerNov 06 '25Sale205.1113,3222,732,4390Nov 07 08:00 PM
Romo TammyDirectorNov 05 '25Sale205.20645132,35434,866Nov 07 08:00 PM
Ramsey R. ScottOfficerNov 06 '25Proposed Sale205.1113,3222,732,412Nov 06 12:39 PM
Romo TammyDirectorNov 03 '25Sale200.8115,0993,031,96947,267Nov 05 08:00 PM
Romo TammyDirectorNov 04 '25Sale204.0711,7562,399,00235,511Nov 05 08:00 PM
Romo TammyDirectorNov 05 '25Proposed Sale205.20645132,351Nov 05 12:45 PM
Romo TammyDirectorNov 04 '25Proposed Sale204.0711,7562,399,032Nov 04 10:32 AM
Romo TammyDirectorNov 03 '25Proposed Sale200.8015,0993,031,953Nov 03 04:16 PM
FISHER RICHARD WDirectorOct 29 '25Sale208.432,500521,0758,792Oct 31 08:00 PM
FISHER RICHARD WDirectorOct 29 '25Proposed Sale208.432,500521,075Oct 29 01:20 PM
Sutaria SaumyaCEOSep 10 '25Sale190.7878,76215,026,139368,683Sep 12 08:00 PM
Sutaria SaumyaOfficerSep 10 '25Proposed Sale190.7878,76215,025,892Sep 10 03:35 PM
Lynch Christopher S.DirectorAug 28 '25Sale183.4481,46812,350Aug 29 08:00 PM
Foo Lisa YEVP, Chief Operating OfficerAug 20 '25Sale179.538,0001,436,24020,878Aug 22 08:00 PM
Lynch Christopher S.DirectorAug 19 '25Sale176.393,952697,09312,358Aug 21 08:00 PM
Foo Lisa YOfficerAug 20 '25Proposed Sale179.538,0001,436,279Aug 20 11:29 AM
FISHER RICHARD WDirectorJun 05 '25Sale173.16836144,76211,292Jun 06 08:00 PM
Arbour Paola MEVP, Chief Information OfficerJun 05 '25Sale173.007,7381,338,67420,110Jun 06 08:00 PM
Arbour Paola MOfficerJun 05 '25Proposed Sale173.007,7381,338,674Jun 05 04:05 PM
FISHER RICHARD WDirectorJun 05 '25Proposed Sale173.15836144,758Jun 05 02:23 PM
BIERMAN JAMES LDirectorMay 29 '25Sale170.004,613784,21035,271May 30 08:00 PM
BIERMAN JAMES LDirectorMay 29 '25Proposed Sale170.004,613784,210May 29 10:53 AM
KERREY J ROBERTDirectorMay 27 '25Sale164.961,222201,58122,377May 28 08:00 PM
FISHER RICHARD WDirectorMay 27 '25Sale165.723,077509,92012,128May 28 08:00 PM
BIERMAN JAMES LDirectorMay 27 '25Sale165.721,551257,03239,884May 28 08:00 PM
BIERMAN JAMES LDirectorMay 23 '25Sale159.5813,8362,208,01741,435May 27 08:00 PM
KERREY J ROBERTDirectorMay 27 '25Proposed Sale164.961,222201,582May 27 05:09 PM
FISHER RICHARD WDirectorMay 27 '25Proposed Sale165.723,077509,920May 27 11:18 AM
BIERMAN JAMES LDirectorMay 27 '25Proposed Sale165.721,551257,032May 27 10:12 AM
Arnst Thomas WEVP, Chief Admin. Officer & GCMay 21 '25Sale166.009,7861,624,4760May 23 08:00 PM
BIERMAN JAMES LDirectorMay 23 '25Proposed Sale159.5813,8362,208,017May 23 11:09 AM
Arnst Thomas WOfficerMay 21 '25Proposed Sale166.009,7861,624,476May 21 10:10 AM
Arbour Paola MEVP, Chief Information OfficerMay 15 '25Sale160.206,4611,035,05227,848May 16 08:00 PM
Arbour Paola MOfficerMay 15 '25Proposed Sale160.206,4611,035,067May 15 11:47 AM
KERREY J ROBERTDirectorMay 09 '25Sale148.505,001742,65322,377May 12 08:00 PM
KERREY J ROBERTDirectorMay 09 '25Proposed Sale148.505,001742,664May 09 04:24 PM
KERREY J ROBERTDirectorMar 11 '25Sale125.439,5251,194,75227,378Mar 12 07:00 PM
KERREY J ROBERTDirectorMar 11 '25Proposed Sale125.809,5251,198,245Mar 11 12:17 PM
HANEY CECIL DDirectorMar 04 '25Sale124.262,500310,65012,035Mar 05 08:00 PM
HANEY CECIL DDirectorMar 04 '25Proposed Sale124.262,500310,650Mar 04 03:08 PM
Last Close
Feb 11  •  04:00PM ET
177.18
Dollar change
-5.27
Percentage change
-2.89
%
IQV IQVIA Holdings Inc daily Stock Chart
IndexS&P 500 P/E22.55 EPS (ttm)7.86 Insider Own0.92% Shs Outstand169.60M Perf Week-12.52%
Market Cap30.17B Forward P/E12.60 EPS next Y14.06 Insider Trans-5.84% Shs Float168.74M Perf Month-26.44%
Enterprise Value44.11B PEG1.33 EPS next Q2.83 Inst Own99.29% Short Float2.70% Perf Quarter-16.84%
Income1.36B P/S1.85 EPS this Y6.73% Inst Trans-3.93% Short Ratio3.00 Perf Half Y-4.70%
Sales16.31B P/B4.62 EPS next Y10.52% ROA4.79% Short Interest4.56M Perf YTD-21.40%
Book/sh38.34 P/C14.09 EPS next 5Y9.45% ROE21.64% 52W High247.04 -28.28% Perf Year-11.80%
Cash/sh12.57 P/FCF14.71 EPS past 3/5Y11.06% 40.52% ROIC6.60% 52W Low134.65 31.59% Perf 3Y-20.49%
Dividend Est.- EV/EBITDA12.86 Sales past 3/5Y4.19% 7.51% Gross Margin26.27% Volatility6.98% 4.37% Perf 5Y-8.13%
Dividend TTM- EV/Sales2.70 EPS Y/Y TTM4.62% Oper. Margin14.02% ATR (14)9.42 Perf 10Y200.31%
Dividend Ex-Date- Quick Ratio0.70 Sales Y/Y TTM5.87% Profit Margin8.34% RSI (14)24.59 Recom1.42
Dividend Gr. 3/5Y- - Current Ratio0.75 EPS Q/Q23.71% SMA20-19.72% Beta1.38 Target Price242.32
Payout0.00% Debt/Eq2.45 Sales Q/Q10.26% SMA50-21.35% Rel Volume2.99 Prev Close182.45
Employees88000 LT Debt/Eq2.17 EarningsFeb 05 BMO SMA200-7.93% Avg Volume1.52M Price177.18
IPOMay 09, 2013 Option/ShortYes / Yes EPS/Sales Surpr.0.64% 2.93% Trades Volume4,558,863 Change-2.89%
Date Action Analyst Rating Change Price Target Change
Dec-02-25Resumed Morgan Stanley Overweight $265
Nov-13-25Initiated BMO Capital Markets Outperform $260
Nov-03-25Downgrade TD Cowen Buy → Hold $215
Oct-29-25Upgrade Robert W. Baird Neutral → Outperform $258
Oct-09-25Upgrade HSBC Securities Hold → Buy $235
Sep-09-25Upgrade Jefferies Hold → Buy $225
Apr-25-25Downgrade HSBC Securities Buy → Hold $160
Apr-10-25Downgrade Barclays Overweight → Equal Weight $170
Feb-03-25Downgrade BTIG Research Buy → Neutral
Dec-20-24Initiated Stephens Overweight $250
Feb-10-26 08:00AM
Feb-08-26 08:39AM
Feb-06-26 07:21PM
09:40AM
12:54AM
12:35AM Loading…
12:35AM
Feb-05-26 04:00PM
12:11PM
11:55AM
09:07AM
08:15AM
07:36AM
07:20AM
07:00AM
Feb-04-26 11:40AM
10:14PM Loading…
Feb-03-26 10:14PM
11:23AM
09:15AM
Jan-29-26 08:00AM
Jan-25-26 11:44AM
Jan-22-26 04:05PM
Jan-20-26 04:45PM
Jan-15-26 09:36AM
Jan-14-26 09:50AM
Jan-13-26 09:11AM
Jan-12-26 11:36PM
Jan-11-26 11:04PM
Jan-09-26 09:40AM
Dec-29-25 12:55PM
Dec-17-25 09:40AM
10:19AM Loading…
Dec-09-25 10:19AM
09:50AM
Dec-04-25 12:21PM
Dec-03-25 10:32PM
Dec-02-25 08:00AM
Nov-28-25 11:30AM
Nov-27-25 11:30AM
Nov-26-25 09:40AM
Nov-11-25 09:50AM
Nov-06-25 10:32PM
12:38PM
12:33PM
Nov-05-25 04:15PM
09:40AM
Nov-04-25 12:31AM
Nov-03-25 01:15PM
09:42AM
Oct-30-25 03:14PM
Oct-29-25 03:45PM
01:31AM
Oct-28-25 08:00PM
01:09PM
08:15AM
07:28AM
07:14AM
07:00AM
Oct-26-25 11:08PM
Oct-23-25 10:19AM
Oct-22-25 10:00AM
Oct-21-25 04:15PM
10:00AM
Oct-20-25 01:35PM
Oct-15-25 04:25AM
Oct-10-25 12:00AM
Oct-09-25 09:37AM
Oct-01-25 06:48PM
04:01PM
10:10AM
Sep-30-25 04:15PM
Sep-29-25 09:43AM
Sep-19-25 09:40AM
08:58AM
Sep-16-25 08:00AM
Sep-11-25 02:16PM
06:09AM
Sep-10-25 08:00AM
04:54AM
Sep-09-25 12:11PM
Sep-03-25 09:40AM
Sep-02-25 09:00AM
Aug-29-25 11:30AM
Aug-28-25 08:00AM
Aug-27-25 09:55AM
Aug-22-25 08:29AM
Aug-21-25 11:30AM
Aug-18-25 11:31PM
09:00AM
Aug-14-25 09:40AM
02:42AM
Aug-13-25 10:57AM
Aug-11-25 09:50AM
05:19AM
Aug-06-25 06:42PM
12:24PM
Aug-05-25 12:23PM
Jul-30-25 10:42AM
Jul-29-25 12:44PM
12:41PM
09:40AM
01:34AM
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOUSBIB ARISee RemarksDec 18 '25Option Exercise59.9050,0002,995,000857,163Dec 19 05:00 PM
BOUSBIB ARISee RemarksDec 18 '25Sale222.4336,5648,132,931820,599Dec 19 05:00 PM
ARI BOUSBIBOfficerDec 18 '25Proposed Sale222.4336,5648,132,876Dec 18 05:41 PM
Sherbet EricSee RemarksOct 29 '25Option Exercise131.8210,0001,318,20031,108Oct 31 05:01 PM
Sherbet EricSee RemarksOct 29 '25Sale219.704,000878,80027,108Oct 31 05:01 PM
BOUSBIB ARISee RemarksOct 29 '25Option Exercise59.9077,5924,647,761884,755Oct 31 05:00 PM
BOUSBIB ARISee RemarksOct 29 '25Sale220.3356,55712,461,119828,198Oct 31 05:00 PM
ARI BOUSBIBOfficerOct 29 '25Proposed Sale220.3356,55712,460,983Oct 29 04:18 PM
ERIC SHERBETOfficerOct 29 '25Proposed Sale219.704,000878,820Oct 29 04:10 PM
Cherofsky KeriannSee RemarksJul 23 '25Sale191.53549105,1502,910Jul 25 05:01 PM
Sherbet EricSee RemarksJul 23 '25Option Exercise97.2011,8701,153,76432,978Jul 25 05:00 PM
Sherbet EricSee RemarksJul 23 '25Sale190.055,8001,102,29027,178Jul 25 05:00 PM
ERIC SHERBETOfficerJul 23 '25Proposed Sale190.055,8001,102,262Jul 23 05:53 PM
KERIANN CHEROFSKYOfficerJul 23 '25Proposed Sale191.53549105,150Jul 23 04:01 PM